Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Human Immunodeficiency Virus - Type 1”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT00090077
What this trial is testing

Monotherapy Versus Placebo Over 7 Days-Non-Nucleoside Reverse Transcriptase Inhibitor-Experienced HIV1 Infected Adults

Who this might be right for
HIV Infections
GlaxoSmithKline 50
Not applicableUnknownNCT05243381
What this trial is testing

Inflammation, NK Cells, Antisense Protein and Exosomes, and Correlation With Immune Response During HIV Infection

Who this might be right for
HIV Infections
University Hospital, Montpellier 60
Early research (Phase 1)Study completedNCT03552536
What this trial is testing

MK-8583 Single Dose Study in Human Immunodeficiency Virus Type 1 (HIV-1) Infected Participants (MK-8583-002)

Who this might be right for
HIV-1 Infection
Merck Sharp & Dohme LLC 5
Post-approval studies (Phase 4)Not Yet RecruitingNCT07584369
What this trial is testing

Short-term Effects of Methamphetamine on Residual Latent HIV Disease Study

Who this might be right for
HIV -1 InfectionMethamphetamine Use
University of California, San Francisco 20
Post-approval studies (Phase 4)Ended earlyNCT01014481
What this trial is testing

Appropriate Timing of HAART in Co-infected HIV/TB Patients

Who this might be right for
HIV InfectionsTuberculosis
Bamrasnaradura Infectious Diseases Institute 156
Testing effectiveness (Phase 2)Ended earlyNCT00294372
What this trial is testing

Phase II Study on the Antiviral Activity and Safety of BILR 355 BS in HIV-1 Infected, NNRTI-treated Patients

Who this might be right for
HIV Infections
Boehringer Ingelheim 36
Not applicableStudy completedNCT00002270
What this trial is testing

A Pilot Study of the Efficacy of Recombinant Alpha Interferon (IFN-A2b) and Zidovudine (AZT) in the Treatment of Progressive Multifocal Leukoencephalopathy (PML) Complicating HIV-1 Infection

Who this might be right for
HIV InfectionsLeukoencephalopathy, Progressive Multifocal
University of Miami
Testing effectiveness (Phase 2)Ended earlyNCT00300573
What this trial is testing

Randomized, Double-Blind Study Comparing Dexelvucitabine (DFC) to Lamivudine (3TC) in Subjects With Resistance to NRTIs, PIs, and NNRTIs

Who this might be right for
HIV InfectionsHuman Immunodeficiency Virus
Incyte Corporation 250
Not applicableNot Yet RecruitingNCT07146529
What this trial is testing

Study of the Prevalence of Transmitted HIV-1 Resistance, Viral Diversity, and Cluster Identification in Patients at the Time of HIV-1 Diagnosis

Who this might be right for
HIV SeropositivityHIV Drug ResistanceHIV Infections
ANRS, Emerging Infectious Diseases 30,060
Not applicableUnknownNCT04354818
What this trial is testing

Coronavirus (COVID-19) Outcomes Registries in Immunocompromised Individuals Australia (CORIA)

Who this might be right for
HIV-1-infectionCancerPrimary Immune Deficiency Disorder+2 more
Kirby Institute 27
Early research (Phase 1)Study completedNCT00007423
What this trial is testing

Safety and Effectiveness of the Vaccine ALVAC-HIV vCP205 in HIV-Negative Adult Volunteers in Uganda

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 40
Early research (Phase 1)Study completedNCT02376582
What this trial is testing

Safety and Immunogenicity Study of a DNA Vaccine Combined With Protein Vaccine Against HIV/AIDS

Who this might be right for
HIV/AIDS
EuroVacc Foundation 72
Not applicableStudy completedNCT03772327
What this trial is testing

HIV Adherence Bottle Intervention Trial

Who this might be right for
HIV-1-infectionAdherence, Medication
Weill Medical College of Cornell University 63
Not applicableLooking for participantsNCT07293559
What this trial is testing

Understanding Practices of Lactation and Infant Feeding Together With Women With HIV in the United States

Who this might be right for
HIV-1-infectionBreastfeedingPregnancy Related
International Maternal Pediatric Adolescent AIDS Clinical Trials Group 1,150
Large-scale testing (Phase 3)Study completedNCT04021290
What this trial is testing

Regimen Switch to Dolutegravir/Lamivudine Fixed Dose Combination From Current Antiretroviral Regimen in HIV-1 Infected and Virologically Suppressed Adults (SALSA)

Who this might be right for
HIV Infections
ViiV Healthcare 493
Early research (Phase 1)Study completedNCT00982579
What this trial is testing

Safety and Immunogenicity Study of Candidate HIV-1 Vaccine Given to Healthy Infants Born to HIV-1/2-uninfected Mothers

Who this might be right for
HIV-1HIV Infections
Medical Research Council 48
Not applicableEnded earlyNCT04024488
What this trial is testing

Group-Based Intervention to Improve Mental Health and Adherence Among Youth Living With HIV in Low Resource Settings

Who this might be right for
HIV-1-infection
International Maternal Pediatric Adolescent AIDS Clinical Trials Group 484
Testing effectiveness (Phase 2)Study completedNCT00000885
What this trial is testing

Treatment Success and Failure in HIV-Infected Subjects Receiving Indinavir in Combination With Nucleoside Analogs: A Rollover Study for ACTG 320

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 440
Not applicableStudy completedNCT01159743
What this trial is testing

A Comparison of Body Fat Distribution in HIV-1 Infected Patients Receiving, Since the Beginning and for at Least Two Years, an Antiretroviral Therapy Based on Efavirenz or Lopinavir/Ritonavir Combined With Tenofovir + Emtricitabine or Lamivudine

Who this might be right for
HIV Infection
AbbVie (prior sponsor, Abbott) 346
Not applicableStudy completedNCT04002323
What this trial is testing

Real Life Study of Dolutegravir Plus Lamivudine in HIV-1-Infected Treatment-Naive Patients

Who this might be right for
HIV-1-infection
University Hospital Virgen de las Nieves 88
Next Page